Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTS-CC: S-1 vs UFT/LV in Stage III Colon Cancer
NCT00660894Phase 3Completed
- Sponsor
- Translational Research Center for Medical Innovation
- Start
- Apr 2008
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tegafur in colon cancer (2 arms), sponsored by Translational Research Center for Medical Innovation. Primary endpoint: Disease-free survival at 3 years. Started Apr 2008; status: completed.
02
Drugs
tegafur
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT00660894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00660894.